0000899866-19-000038.txt : 20190304
0000899866-19-000038.hdr.sgml : 20190304
20190304173757
ACCESSION NUMBER: 0000899866-19-000038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clancy Paul J
CENTRAL INDEX KEY: 0001409601
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27756
FILM NUMBER: 19655439
MAIL ADDRESS:
STREET 1: C/O BIOGEN IDEC INC.
STREET 2: 14 CAMBRIDGE CENTER
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000899866
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133648318
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 4752302596
MAIL ADDRESS:
STREET 1: 121 SEAPORT BOULEVARD
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960111
4
1
wf-form4_155173906391052.xml
FORM 4
X0306
4
2019-02-28
0
0000899866
ALEXION PHARMACEUTICALS, INC.
ALXN
0001409601
Clancy Paul J
C/O ALEXION PHARMACEUTICALS, INC.
121 SEAPORT BLVD
BOSTON
MA
02210
0
1
0
0
EVP, Chief Financial Officer
Common Stock, par value $.0001 per share
2019-02-28
4
F
0
1079
132.93
D
86249
D
This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.90- $135.01. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
/s/ Douglas Barry, Attorney-in-Fact for Paul J. Clancy
2019-03-04